Showing results (41-50 of 55) with videos related to
Sort By:
Pageof 6
Human Molecular Genetics|August 11, 2016
Overlap of abnormal photoreceptor development and progressive degeneration in Leber congenital amaurosis caused by NPHP5 mutationLouise M Downs, Erin M Scott, Artur V Cideciyan, et al.Investigative Ophthalmology & Visual Science|February 28, 2007
Macular pigment and lutein supplementation in ABCA4-associated retinal degenerationsTomas S Aleman, Artur V Cideciyan, Elizabeth A M Windsor, et al.Human Gene Therapy|May 17, 2020
Dose Range Finding Studies with Two <i>RPGR</i> Transgenes in a Canine Model of X-Linked Retinitis Pigmentosa Treated with Subretinal Gene TherapyChunjuan Song, Valérie L Dufour, Artur V Cideciyan, et al.Proceedings of the National Academy of Sciences of the United States of America|October 14, 2015
Successful arrest of photoreceptor and vision loss expands the therapeutic window of retinal gene therapy to later stages of diseaseWilliam A Beltran, Artur V Cideciyan, Simone Iwabe, et al.Proceedings of the National Academy of Sciences of the United States of America|March 7, 2018
<i>BEST1</i> gene therapy corrects a diffuse retina-wide microdetachment modulated by light exposureKarina E Guziewicz, Artur V Cideciyan, William A Beltran, et al.Ophthalmology Science|October 17, 2022
Restoration of Cone Sensitivity to Individuals with Congenital Photoreceptor Blindness within the Phase 1/2 Sepofarsen TrialArtur V Cideciyan, Samuel G Jacobson, Allen C Ho, et al.Iscience|October 24, 2022
Night vision restored in days after decades of congenital blindnessSamuel G Jacobson, Artur V Cideciyan, Allen C Ho, et al.International Journal of Molecular Sciences|October 16, 2024
Evaluation of Retinal Structure and Visual Function in Blue Cone Monochromacy to Develop Clinical Endpoints for L-opsin Gene TherapyArtur V Cideciyan, Alejandro J Roman, Raymond L Warner, et al.Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosaWilliam A Beltran, Artur V Cideciyan, Alfred S Lewin, et al.Lancet (London, England)|September 7, 2024
Safety and efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D: a phase 1/2, multicentre, open-label, unilateral dose escalation studyPaul Yang, Laura P Pardon, Allen C Ho, et al.Pageof 6